Hitachi Launches Expanded HMAX Solutions Accelerating Social Innovation Globally Across Industries
A Suite of Solutions Leveraging Advanced AI with Company’s Deep Domain Knowledge of Social Infrastructure SANTA CLARA, Calif.–(BUSINESS WIRE)–#AI–Hitachi,... Read more.
Claritev Corporation to Present at J.P. Morgan Healthcare Conference
MCLEAN, Va.–(BUSINESS WIRE)–Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused... Read more.
dynaCERT Lead Director, Doug Seneshen, Retires
TORONTO–(BUSINESS WIRE)–$DMJ #carbonemissions—dynaCERT Inc. (TSX: DYA) (OTCQB: DYFSF) (FRA: DMJ) (“dynaCERT” or the “Company”)... Read more.
Newline Group Announces New Leadership Appointments
LONDON–(BUSINESS WIRE)–Newline Group (Newline) today announced the appointment of James May as Head of General Liability and Ben Ward as Head of Life... Read more.
Paris Saint-Germain Partners With Zing Coach Until 2027 to Encourage Fans to Get Active Through Interactive Fitness Experiences
Paris Saint-Germain’s global fanbase will be offered the chance to engage in training routines modeled after their favorite Women and Men star players through... Read more.
KAYTUS Completes 100-Cabinet Liquid-Cooled Data Center in Europe in Four Months
KAYTUS turnkey modular solution delivered with onsite professional services, improved high-density liquid cooling cluster performance by 20%, and deployment efficiency... Read more.
Ikarovec to Advance Pipeline With Exclusive Worldwide Option to VectorBuilder’s Intravitreal Capsid Technology
Novel capsid technology to enable convenient delivery in the doctor’s office of IKAR-003 for intermediate AMD, designed to prevent progression to sight-threatening... Read more.
Kashiv BioSciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
PISCATAWAY, N.J.–(BUSINESS WIRE)–Kashiv BioSciences, LLC (“Kashiv”), a vertically integrated biopharmaceutical company, today announced that Dr.... Read more.
Iksuda to Present Preliminary Analysis of Oesophageal Cancer Data From Phase 1 study of IKS014 at ASCO Gastrointestinal Cancer Symposium
Encouraging anti-tumour activity seen across all dose levels and in various tumour indications Clinical benefit rate of 80% for 10 patients with HER2+ oesophageal... Read more.
FRMI CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Fermi Inc.
LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz announces that it has filed a class action lawsuit in the United States District Court for... Read more.